Literature DB >> 24126060

Over expression of PPP2R2C inhibits human glioma cells growth through the suppression of mTOR pathway.

Yi-Ling Fan1, Lei Chen, Ji Wang, Qing Yao, Jie-Qing Wan.   

Abstract

PPP2R2C encodes a gamma isoform of the subunit B55 subfamily, which is a regulatory subunit of Protein phosphatase type 2A (PP2A). Our study shows that PPP2R2C is downregulated in glioma cells and human brain cancer patient samples. Overexpression of PPP2R2C inhibited cancer cell proliferation both in vitro and in vivo through the suppression of the activity of S6K in the mTOR pathway. Moreover, exogenous expression of PPP2R2C promoted the formation of a complex with the PP2A-C subunit to further enhance the binding of PP2A-C with S6K. Our results suggest that PPP2R2C is a potential tumor suppressor gene in human brain cancers. This study will provide novel insight into the development of therapeutic strategies in the treatment of human brain tumors.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  B55 Gamma; PPP2R2C; mTOR; p-S6K

Mesh:

Substances:

Year:  2013        PMID: 24126060     DOI: 10.1016/j.febslet.2013.09.029

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Serine-threonine protein phosphatases: Lost in translation.

Authors:  Victoria Kolupaeva
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-08-20       Impact factor: 4.739

2.  Selective PP2A Enhancement through Biased Heterotrimer Stabilization.

Authors:  Daniel Leonard; Wei Huang; Sudeh Izadmehr; Caitlin M O'Connor; Danica D Wiredja; Zhizhi Wang; Nilesh Zaware; Yinghua Chen; Daniela M Schlatzer; Janna Kiselar; Nikhil Vasireddi; Stefan Schüchner; Abbey L Perl; Matthew D Galsky; Wenqing Xu; David L Brautigan; Egon Ogris; Derek J Taylor; Goutham Narla
Journal:  Cell       Date:  2020-04-20       Impact factor: 41.582

Review 3.  Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.

Authors:  Md Nematullah; M N Hoda; Farah Khan
Journal:  Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.590

Review 4.  Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.

Authors:  Jerry Vriend; Thomas Klonisch
Journal:  Cell Mol Neurobiol       Date:  2022-07-27       Impact factor: 4.231

5.  Chronic arsenic exposure suppresses ATM pathway activation in human keratinocytes.

Authors:  Alexandra N Nail; Lakynkalina M McCaffrey; Mayukh Banerjee; Ana P Ferragut Cardoso; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2022-05-02       Impact factor: 4.460

Review 6.  All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase.

Authors:  Jaya Sangodkar; Caroline C Farrington; Kimberly McClinch; Matthew D Galsky; David B Kastrinsky; Goutham Narla
Journal:  FEBS J       Date:  2015-11-14       Impact factor: 5.542

7.  The association between Salt-inducible kinase 2 (SIK2) and gamma isoform of the regulatory subunit B55 of PP2A (B55gamma) contributes to the survival of glioma cells under glucose depletion through inhibiting the phosphorylation of S6K.

Authors:  Ya-Nan Li; Yi-Qun Cao; Xi Wu; Guo-Sheng Han; Lai-Xing Wang; Yu-Hui Zhang; Xin Chen; Bin Hao; Zhi-Jian Yue; Jian-Min Liu
Journal:  Cancer Cell Int       Date:  2015-02-18       Impact factor: 5.722

Review 8.  Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.

Authors:  Priyanka Sandal; Chian Ju Jong; Ronald A Merrill; Jianing Song; Stefan Strack
Journal:  J Cell Sci       Date:  2021-07-06       Impact factor: 5.235

9.  The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.

Authors:  Feng Zhi; Qiang Wang; Lian Xue; Naiyuan Shao; Rong Wang; Danni Deng; Suinuan Wang; Xiwei Xia; Yilin Yang
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 10.  Molecular crosstalk between cancer and neurodegenerative diseases.

Authors:  Jiyeon Seo; Mikyoung Park
Journal:  Cell Mol Life Sci       Date:  2019-12-28       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.